Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://mas.to/users/statsguy/statuses/112772470304031764">Adam Jacobs 🇺🇦 (statsguy@mas.to)'s status on Friday, 12-Jul-2024 17:06:20 JST</a><a href="https://mas.to/@statsguy" title="statsguy@mas.to"><img src="https://gnusocial.jp/avatar/20006-48-20240311201139.webp" width="48" height="48" alt="Adam Jacobs 🇺🇦" style="position: absolute; left: 0; top: 0;">Adam Jacobs 🇺🇦</a></section><article><p>Nice try Wiley, but no, I'm not going to fill in that form with oodles of personal data that you seem to need (why?) before I can download my certificate.</p><p>I'm just going to have to try to manage without a certificate to celebrate my achievement of publishing one of the top 10% of papers in a single medium-tier journal in a 2 year period (if that's even true).</p><p>It'll be tough, for sure, but I'll do my best to get by.</p><p><a href="https://mas.to/tags/AcademicPublishing" rel="tag">#AcademicPublishing</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3364036#notice-6621097">In conversation</a><time datetime="2024-07-12T17:06:20+09:00" title="Friday, 12-Jul-2024 17:06:20 JST">about 6 months ago</time> <span>from <span><a href="https://mas.to/@statsguy/112772470304031764" rel="external" title="Sent from mas.to via ActivityPub">mas.to</a></span></span><a href="https://mas.to/@statsguy/112772470304031764">permalink</a><h4>Attachments</h4><ol><li><label><a rel="external" href="https://gnusocial.jp/attachment/2896891">Screenshot of an email from Wiley:CongratulationsYour work is one of our most-cited papers.Download this certificate of achievement celebrating your success.Dear Adam Jacobs,We are delighted to share that your work, published in Pain Practice on behalf of World Institute of Pain, is one of our top 10 most-cited papers published*:•	Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial</a></label><br><a href="https://media.mas.to/media_attachments/files/112/772/452/720/031/685/original/83f55108b9c114f4.png" rel="external">https://media.mas.to/media_attachments/files/112/772/452/720/031/685/original/83f55108b9c114f4.png</a></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Adam Jacobs 🇺🇦 (statsguy@mas.to)'s status on Friday, 12-Jul-2024 17:06:20 JST Adam Jacobs 🇺🇦
Nice try Wiley, but no, I'm not going to fill in that form with oodles of personal data that you seem to need (why?) before I can download my certificate.
I'm just going to have to try to manage without a certificate to celebrate my achievement of publishing one of the top 10% of papers in a single medium-tier journal in a 2 year period (if that's even true).
It'll be tough, for sure, but I'll do my best to get by.
#AcademicPublishing
In conversationabout 6 months ago from mas.topermalink
Attachments
1. Screenshot of an email from Wiley: Congratulations Your work is one of our most-cited papers. Download this certificate of achievement celebrating your success. Dear Adam Jacobs, We are delighted to share that your work, published in Pain Practice on behalf of World Institute of Pain, is one of our top 10 most-cited papers published*: • Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial
  https://media.mas.to/media_attachments/files/112/772/452/720/031/685/original/83f55108b9c114f4.png

Public

Embed Notice

HTML Code

Corresponding Notice